- Home
- SVRA vs AROW Comparison
SVRA vs AROW Comparison
Compare SVRA & AROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- AROW
- Stock Information
- Founded
- SVRA 2007
- AROW 1851
- Country
- SVRA United States
- AROW United States
- Employees
- SVRA N/A
- AROW N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- AROW Major Banks
- Sector
- SVRA Health Care
- AROW Finance
- Exchange
- SVRA Nasdaq
- AROW Nasdaq
- Market Cap
- SVRA 433.8M
- AROW 432.9M
- IPO Year
- SVRA N/A
- AROW N/A
- Fundamental
- Price
- SVRA $2.58
- AROW $26.85
- Analyst Decision
- SVRA Buy
- AROW Hold
- Analyst Count
- SVRA 5
- AROW 1
- Target Price
- SVRA $5.60
- AROW $28.00
- AVG Volume (30 Days)
- SVRA 1.3M
- AROW 35.9K
- Earning Date
- SVRA 08-11-2025
- AROW 07-24-2025
- Dividend Yield
- SVRA N/A
- AROW 4.17%
- EPS Growth
- SVRA N/A
- AROW N/A
- EPS
- SVRA N/A
- AROW 1.83
- Revenue
- SVRA N/A
- AROW $140,422,000.00
- Revenue This Year
- SVRA N/A
- AROW $23.65
- Revenue Next Year
- SVRA N/A
- AROW $7.05
- P/E Ratio
- SVRA N/A
- AROW $14.69
- Revenue Growth
- SVRA N/A
- AROW 5.15
- 52 Week Low
- SVRA $1.89
- AROW $22.72
- 52 Week High
- SVRA $4.74
- AROW $34.63
- Technical
- Relative Strength Index (RSI)
- SVRA 59.80
- AROW 50.90
- Support Level
- SVRA $2.25
- AROW $26.38
- Resistance Level
- SVRA $2.39
- AROW $27.45
- Average True Range (ATR)
- SVRA 0.15
- AROW 0.59
- MACD
- SVRA 0.04
- AROW -0.09
- Stochastic Oscillator
- SVRA 88.61
- AROW 30.00
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About AROW Arrow Financial Corporation
Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.